NASDAQ
Black Diamond Therapeutics, Inc. (BDTX) has a fcf yield of 21.43% as of Friday, May 29, 2026. This represents a 129.45% increase compared to its 12-month average of -72.76%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.